Mustang Bio Inc (MBIO) News

MBIO MONSTER POST SPLIT

MBIO BIO POST SPLIT BEAST

Stargate will help fund cures for cancer

5 million to take out the float does not sound like a lot for fortress would push stock past 20$

What is fortress going to do loose their money or make a play?

MBIO...26s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 670065

Friday, January 10, 2025 10:21:18 AM

Post#
671024
of 671059
MBIO...24s clearing here ...🥳Volume hitting...Hit .43 a few days ago...

georgie18

Member Level
Re: georgie18 post# 213

Thursday, January 02, 2025 10:59:21 AM

Post#
215
of 250
MBIO...38...🥳...Gonna be a big winner today...

georgie18

Member Level
Re: georgie18 post# 669337

Thursday, January 02, 2025 10:49:55 AM

Post#
670058
of 670064
MBIO...2979...🥳...Breaking out here...

georgie18

Member Level
Re: georgie18 post# 211

Friday, December 27, 2024 4:47:14 PM

Post#
212
of 212
MBIO....1927...🥳... https://schrts.co/SXHJicSE ...Reversal setting up here...imo...we shall see...

Member Level
Re: georgie18 post# 664533

Wednesday, December 04, 2024 8:24:43 AM

Post#
666634
of 669335
MBIO....1989...Been accumulating from .10 /30 range...🥳

georgie18

Member Level
Re: georgie18 post# 209

Tuesday, November 12, 2024 8:37:06 AM

Post#
210
of 210
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.

MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html

georgie18

Member Level
Re: georgie18 post# 206

Wednesday, October 30, 2024 12:45:35 PM

Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...

georgie18

Member Level
Re: georgie18 post# 662593

Friday, October 25, 2024 2:32:02 PM

Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...

MBIO...24s clearing here ...🥳Volume hitting...Hit .43 a few days ago...

georgie18

Member Level
Re: georgie18 post# 213

Thursday, January 02, 2025 10:59:21 AM

Post#
215
of 250
MBIO...38...🥳...Gonna be a big winner today...

georgie18

Member Level
Re: georgie18 post# 669337

Thursday, January 02, 2025 10:49:55 AM

Post#
670058
of 670064
MBIO...2979...🥳...Breaking out here...

georgie18

Member Level
Re: georgie18 post# 211

Friday, December 27, 2024 4:47:14 PM

Post#
212
of 212
MBIO....1927...🥳... https://schrts.co/SXHJicSE ...Reversal setting up here...imo...we shall see...

Member Level
Re: georgie18 post# 664533

Wednesday, December 04, 2024 8:24:43 AM

Post#
666634
of 669335
MBIO....1989...Been accumulating from .10 /30 range...🥳

georgie18

Member Level
Re: georgie18 post# 209

Tuesday, November 12, 2024 8:37:06 AM

Post#
210
of 210
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.

MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html

georgie18

Member Level
Re: georgie18 post# 206

Wednesday, October 30, 2024 12:45:35 PM

Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...

georgie18

Member Level
Re: georgie18 post# 662593

Friday, October 25, 2024 2:32:02 PM

Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...

MBIO.........................https://stockcharts.com/h-sc/ui?s=MBIO&p=W&b=5&g=0&id=p86431144783

https://www.griproom.com/fun/12-signs-your-stock-is-targeted-for-buyout-theft

MBIO: You too, Dude!!! (One wild-&-crazy FRIDAY, this one!!!)

Guess I was wrong lol. Next week. Have a great weekend

MBIO: THANKS for the heads-up, Bro!!

MBIO is ready!

lol I love star trek

@CRIS: O.K., nice tip!!

A joke someone told me, decades sago:

"What does the Star Ship ENTERPRISE have in common with a fist full of TOILET PAPER? They both circle URANUS, searching for KLINGONS!!"

CRIS

Treatment for Cancer. Patent pending

Heck, I didn't have @FFIE --- nor its often screaming WARRANTS --- in my watch list today!!

Trade sizes are much bigger. Nice volume thin it’s gonna go kaboom here power hour in my opinion of course lol

Thanks!! (Just an average Fellow, on the West Coast --- which AIN'T the place to be playin' Wall Street, behind that 3-hour TIME differential!! Maybe TRUMP can move "Wall Street" to at least the MIDDLE of the USA!!)

I’m partial to Uranus to be honest lmfao

Indeed, Dude --- and when those GAPS disappear, and stay that way, well, we could be on a trip to JUPITER, & beyond!!!

FFIE
Fib hit

Private Messaging: To me, the ONLY benefit of iHub's "Private Messaging" routine, is the ability to quickly see if ANYBODY across the entire iHub platform has posted about a particular stock I may be interested in at any given moment.

I was looking at NITO but chose this. Congrats man!! Or woman !!!

I like volume before price

I don’t think I have to tell you the gaps always have to be filled lol

MBIO: Yep, those nasty GAPS, between the Bids & Asks!! (I did great today via my early @CTCX & @NITO gambits; but constantly eyeballing those damn GAPS puts me, "UNDER PRESSURE'!!!)

Ihub sucks lol been here for a long time. First time I bought level 2 and pming. Lol

MBIO: I don't have iHub's "Private Messaging" right now --- so, regarding your comments about our Pres. TRUMP down here, I didn't vote for him. However, since he wants to totally abandon that nasty "DAYLIGHT SAVINGS TIME" crap every year, well, I am beginning to LIKE Mr. Trump a lot MORE, every day!!!

Methinks the gap might bet filled

Hey, many (even strangers) have told me that, Dude!!

Lmfao. You look just like Rodney Dangerfield lol

MBIO: In passing, your iHub Profile says that you're a Gynecologist!! So am I, over here in San Diego!! (See me live right now, below, EXAMINING a few of my Patients!!)

Keep coming down to papa!! Big bounce coming soon I feeleth

LMFAO!! That’s funny. But it’s good to be in the know eh???!! lol thanks for the laugh!!

MBIO: As you SHOULD be, Homeboy!!! (I just like bustin' King Georgie's Knuts, once-in-a-while!! He 'alerted' everything --- even the American Revolutionary WAR!!!)

MBIO.......................https://stockcharts.com/h-sc/ui?s=MBIO&p=W&b=5&g=0&id=p86431144783

First trading day of the year has been wonderful, my friend!

Crazy lol. I’m having fun lol

MBIO: A WILD price ride over here today, Georgie!!! (But I know you've been scalpin', & flippin', & otherwise BANKING all day long with this little puppy today, Dude!!!)

in at .24 adding

MBIO...38...🥳...Gonna be a big winner today...

georgie18

Member Level
Re: georgie18 post# 669337

Thursday, January 02, 2025 10:49:55 AM

Post#
670058
of 670064
MBIO...2979...🥳...Breaking out here...

georgie18

Member Level
Re: georgie18 post# 211

Friday, December 27, 2024 4:47:14 PM

Post#
212
of 212
MBIO....1927...🥳... https://schrts.co/SXHJicSE ...Reversal setting up here...imo...we shall see...

Member Level
Re: georgie18 post# 664533

Wednesday, December 04, 2024 8:24:43 AM

Post#
666634
of 669335
MBIO....1989...Been accumulating from .10 /30 range...🥳

georgie18

Member Level
Re: georgie18 post# 209

Tuesday, November 12, 2024 8:37:06 AM

Post#
210
of 210
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.

MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html

georgie18

Member Level
Re: georgie18 post# 206

Wednesday, October 30, 2024 12:45:35 PM

Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...

georgie18

Member Level
Re: georgie18 post# 662593

Friday, October 25, 2024 2:32:02 PM

Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...

MBIO: And it's all YOURS, King Georgie!!!

MBIO...2979...🥳...Breaking out here...

georgie18

Member Level
Re: georgie18 post# 211

Friday, December 27, 2024 4:47:14 PM

Post#
212
of 212
MBIO....1927...🥳... https://schrts.co/SXHJicSE ...Reversal setting up here...imo...we shall see...

Member Level
Re: georgie18 post# 664533

Wednesday, December 04, 2024 8:24:43 AM

Post#
666634
of 669335
MBIO....1989...Been accumulating from .10 /30 range...🥳

georgie18

Member Level
Re: georgie18 post# 209

Tuesday, November 12, 2024 8:37:06 AM

Post#
210
of 210
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.

MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html

georgie18

Member Level
Re: georgie18 post# 206

Wednesday, October 30, 2024 12:45:35 PM

Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...

georgie18

Member Level
Re: georgie18 post# 662593

Friday, October 25, 2024 2:32:02 PM

Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...

MBIO....1927...🥳... https://schrts.co/SXHJicSE ...Reversal setting up here...imo...we shall see...

Member Level
Re: georgie18 post# 664533

Wednesday, December 04, 2024 8:24:43 AM

Post#
666634
of 669335
MBIO....1989...Been accumulating from .10 /30 range...🥳

georgie18

Member Level
Re: georgie18 post# 209

Tuesday, November 12, 2024 8:37:06 AM

Post#
210
of 210
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.

MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html

georgie18

Member Level
Re: georgie18 post# 206

Wednesday, October 30, 2024 12:45:35 PM

Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...

georgie18

Member Level
Re: georgie18 post# 662593

Friday, October 25, 2024 2:32:02 PM

Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...

MBIO....1989...Been accumulating from .10 /30 range...🥳

georgie18

Member Level
Re: georgie18 post# 209

Tuesday, November 12, 2024 8:37:06 AM

Post#
210
of 210
MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.

MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html

georgie18

Member Level
Re: georgie18 post# 206

Wednesday, October 30, 2024 12:45:35 PM

Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...

georgie18

Member Level
Re: georgie18 post# 662593

Friday, October 25, 2024 2:32:02 PM

Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...

MBIO...258...🥳...WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however, there can be no assurance that the Company will be able to do so.

MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html

georgie18

Member Level
Re: georgie18 post# 206

Wednesday, October 30, 2024 12:45:35 PM

Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...

georgie18

Member Level
Re: georgie18 post# 662593

Friday, October 25, 2024 2:32:02 PM

Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...

MBIO...266...🥳...https://www.globenewswire.com/news-release/2024/11/07/2976708/0/en/Mustang-Bio-Granted-Orphan-Drug-Designation-by-U-S-FDA-for-MB-108-HSV-1-oncolytic-virus-to-Treat-Malignant-Glioma.html

georgie18

Member Level
Re: georgie18 post# 206

Wednesday, October 30, 2024 12:45:35 PM

Post#
207
of 209
MBIO...33...Added here...Break/Hold .38 and she sees .50plus...imo...we shall see...

georgie18

Member Level
Re: georgie18 post# 662593

Friday, October 25, 2024 2:32:02 PM

Post#
662803
of 663273
MBIO...30s clearing here...🥳...Recent alert at .27 ran to .60 plus range...Break/Hold .37 is what I am looking for...then it should push .50 range...imo...we shall see...

Have a Great Weekend Y'all...🥳